BAY 383045

Drug Profile

BAY 383045

Alternative Names: PDE 1/5 inhibitor - Bayer; PDE I/V inhibitor - Bayer; Phosphodiesterase I/V inhibitor - Bayer

Latest Information Update: 09 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer
  • Class
  • Mechanism of Action Type 1 cyclic nucleotide phosphodiesterase inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Angina pectoris; Myocardial infarction

Most Recent Events

  • 10 May 1999 New profile
  • 10 May 1999 Preclinical development for Angina pectoris in Germany (Unknown route)
  • 10 May 1999 Preclinical development for Myocardial infarction in Germany (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top